Global Cardiac Rhythm Management Devices Market 2015-2019
About cardiac rhythm management devices
Cardiac rhythm management, a part of electrophysiology, is a field of cardiovascular disease therapy that provides treatment and diagnosis for heart disorders. Cardiac rhythm management devices (including implantable defibrillators and bi ventricular pacemakers) are used to manage heart rhythm problems such as bradycardia and tachycardia.
Rise in cholesterol levels, hypertension, and excessive smoking lead to high risks of cardiac disorders, resulting in the growing need for cardiovascular therapeutic instruments such as CRT devices. Governments and organizations in many countries implement various initiatives to educate and help people to make medical decisions, increase public awareness, and improve the quality of life. Pacemakers, ICDs, and CRT devices are used to treat arrhythmias and are considered as a standard treatment option in many countries.
Technavio's analysts forecast the global cardiac rhythm management devices market to grow at a CAGR of 1.08% over the period 2014-2019.
Covered in this report
The report includes the present scenario and the growth prospects of the global cardiac rhythm management devices market for the period 2015-2019. Based on product types, the market can be segmented into: pacemaker, ICD, and CRT (including CRT-D and CRT-P).
Technavio's report, Global Cardiac Rhythm Management Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global cardiac rhythm management devices market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.Key regions
Technavio Announces the Publication of its Research Report – Global Cardiac Rhythm Management Devices Market 2015-2019.
Technavio recognizes the following companies as the key players in the Global Cardiac Rhythm Management Devices Market: Boston Scientific, Medtronic and St. Jude Medical
Other Prominent Vendors in the market are: Abbott Laboratories, Adam, Rouilly, Advanced Instrumentations, Altera, Biotronik, Cardiac Science (a subsidiary of Opto Circuits), CardiAid, Cardioline, E&M Electromedicina, EMTEL, Fukuda Denshi, Hagenuk, Instramed, Mediana, Mentice, Medical ECONET, Mindray, Physio Control, Philips Healthcare and Sorin
Commenting on the report, an analyst from Technavio’s team said: “The major trend in this market is robotic technology provides physicians with an excellent view of the operative field and the ability to maneuver instruments within close-fitting spaces with precision and control. Robot-assisted surgical procedures help reduce patient hospital stays, facilitating better cost management.”
According to the report, one major driver is Incidences of cardiac disorders such as bradycardia, sick sinus syndrome, atrioventricular blocks, ventricular fibrillation, cardiac arrest, and tachycardia have increased globally over the past few years.
Further, the report states that one of the major challenges is the post-surgery complications associated with the implantation of cardiac rhythm management devices include infections, hematoma, inflammation, thrombosis, bleeding, over-sensing, failure to terminate arrhythmia episodes, and bruising.
Boston Scientific, Medtronic, St. Jude Medical, Abbott Laboratories, Adam, Rouilly, Advanced Instrumentations, Altera, Biotronik, Cardiac Science (a subsidiary of Opto Circuits), CardiAid, Cardioline, E&M Electromedicina, EMTEL, Fukuda Denshi, Hagenuk, Instramed, Mediana, Mentice, Medical ECONET, Mindray, Physio Control, Philips Healthcare, Sorin